Skip to main content
. 2022 Jun 27;12(7):1053. doi: 10.3390/jpm12071053

Table 1.

Inclusion criteria of the present meta-analysis. ALT, alanine aminotransferase; AST, aspartate aminotransferase.

Inclusion Criteria Description
Population Patients with chronic liver disease
Intervention Taking the target drugs, including carnitine-orotate, carnitine-orotate complex, and L-carnitine
Comparison No target drugs
Outcomes Proportion of patients with ALT normalization or difference in post-treatment serum AST and ALT levels
Study design Randomized controlled trial